We present here three studies focused on demonstrating the safety of the new vaccine HIPRABOVIS® IBR Marker Live due to the intrinsic characteristics of the double deleted strain (strain CEDDEL) that contains 3 trials. Trial 1: dissemination, shedding and latency; Trial 2: latency, reactivation and re-excretion; Trial 3: abortigenicity and passage through the placenta.
Safety of a new attenuated IBR live vaccine with double genetic deletion gE-tk- dissemination, latency/re-excretion and abortigenicity: 3 trials assaying very high doses
Ấn phẩm
Gia súc
Tải về bài báo này
Những ấn phẩm liên quan
Tin tức mới nhất
Khám phá những tin tức mới nhất của chúng tôi